Attention-deficit/hyperactivity disorder and cardiometabolic risk profile in patients with acute myocardial infarction: data from the SWEDEHEART registry
Open Access
- 11 April 2025
- journal article
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
Abstract
Aims: Attention-deficit/hyperactivity disorder (ADHD) is increasingly diagnosed in adults and is associated with cardiometabolic diseases. Yet, the associations between ADHD and cardiometabolic risk profile, participation in non-pharmacological interventions, and long-term outcomes in patients with myocardial infarction (MI) remain unclear. Methods and results: This observational study involved patients from the SWEDEHEART (the Swedish Web-system for Enhancement and Development of Evidence-based Care in Heart Disease Evaluated According to Recommended Therapy) registry, aged 18–74 years old, diagnosed with their first acute MI from 2006 to 2020. We assessed the associations between ADHD and cardiometabolic risk profile (clinical parameters, disease histories, and behavioural factors), engagement in guideline-recommended non-pharmacological interventions, recurrent cardiovascular events, and mortality. We analysed adults with MI with ADHD (n = 582) and without ADHD (n = 2704). Most clinical parameters and disease histories did not differ significantly between groups. However, patients with ADHD had higher risks of smoking (risk ratio, RR = 1.53; 95% confidence interval 1.36–1.71] and snus use (RR = 1.65; 1.36–1.99), were less likely to participate in follow-up evaluations (RR = 0.87; 0.79–0.96), or to stop smoking after MI (RR = 0.76; 0.63–0.91). They had a higher rate of all-cause mortality (hazard ratio = 2.02; 1.05–3.88) after discharge, but not recurrent cardiovascular events. Conclusion: Adults with MI and ADHD present similar cardiometabolic risk profiles but poorer lifestyle behaviours, lower engagement in recommended interventions, and higher mortality compared with those without ADHD, underscoring the need for integrated cardiology care with psychiatric services.Keywords
This publication has 38 references indexed in Scilit:
- ADHD Pharmacotherapy and Mortality in Individuals With ADHDJAMA, 2024
- Attention‐deficit/hyperactivity disorder is associated with increased risk of cardiovascular diseases: A systematic review and meta‐analysisJCPP Advances, 2023
- The association between type 2 diabetes and attention- deficit/hyperactivity disorder: A systematic review, meta-analysis, and population-based sibling studyNeuroscience & Biobehavioral Reviews, 2023
- Attention‐deficit/hyperactivity disorder as a risk factor for cardiovascular diseases: a nationwide population‐based cohort studyWorld Psychiatry, 2022
- Prevalence of psychoactive drug use in patients hospitalized for acute cardiac events: Rationale and design of the ADDICT-ICCU trial, from the Emergency and Acute Cardiovascular Care Working Group and the National College of Cardiologists in Training of the French Society of CardiologyArchives of Cardiovascular Diseases, 2022
- Clustering with missing data: which equivalent for Rubin’s rules?Advances in Data Analysis and Classification, 2022
- The management of ADHD in children and adolescents: bringing evidence to the clinic: perspective from the European ADHD Guidelines Group (EAGG)European Child & Adolescent Psychiatry, 2021
- Prevalence of attention-deficit/hyperactivity disorder in older adults: A systematic review and meta-analysisNeuroscience & Biobehavioral Reviews, 2020
- Association of Smoking Cessation and Survival Among Young Adults With Myocardial Infarction in the Partners YOUNG-MI RegistryJAMA Network Open, 2020
- Why does ADHD Confer Risk for Cigarette Smoking? A Review of Psychosocial MechanismsClinical Child and Family Psychology Review, 2010